0001179110-17-002810.txt : 20170221
0001179110-17-002810.hdr.sgml : 20170221
20170221175142
ACCESSION NUMBER: 0001179110-17-002810
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170216
FILED AS OF DATE: 20170221
DATE AS OF CHANGE: 20170221
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HURWICH THOMAS A.
CENTRAL INDEX KEY: 0001563573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 17626300
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2017-02-16
0
0001551152
AbbVie Inc.
ABBV
0001563573
HURWICH THOMAS A.
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
VP, Controller
Common stock, $0.01 par value
2017-02-16
4
A
0
5612
0
A
67061
D
Common stock, $0.01 par value
2017-02-16
4
A
0
2526
0
A
69587
D
Common stock, $0.01 par value
447
I
Profit sharing trust
Common stock, $0.01 par value
274
I
By spouse in IRA
Option (right to buy)
61.36
2017-02-16
4
A
0
13050
0
A
2018-02-16
2027-02-15
Common shares
13050
13050
D
Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on adjusted earnings per share and relative total shareholder return measures. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017.
Represents shares of AbbVie common stock issued under a performance-vested restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2017.
Balance in the AbbVie Savings Program as of February 16, 2017.
The reporting person disclaims beneficial ownership of all securities held by his spouse.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exercisable in annual increments of 4,350 on 02/16/2018, 4,350 on 02/16/2019, and 4,350 on 02/16/2020.
Steven L. Scrogham, attorney-in-fact for Thomas A. Hurwich
2017-02-21